ST. LOUIS — Five additional companies, including two in St. Louis, have been awarded medical marijuana infused-product licenses because duplicate licenses were mistakenly issued, the Missouri Department of Health and Senior Services (DHSS) reported.
Five infused-product manufacturing facilities submitted duplicate applications and received more than one license for a single facility, DHSS said. There was no prohibition against duplicate applications, but “one facility can only utilize one license,” DHSS said.
The five new licensees, who were next in line in the scoring of applications, are:
MidAmeriCanna, 2849 Union Blvd., St. Louis Nature’s Med MO, 3615 Tree Court Industrial Blvd., St. Louis ROI Labs of Atherton , 4610 N Main St, Independence Missouri Made Marijuana,, 301 S. Outer Belt Road E., Grain Valley Kings Garden Midwest, 3300 Pleasant Place, Trenton
Missouri authorized 60….
Read More Here
According to definition, an entourage is a group of people attending to an important person — such as a group of bodyguards. Another interpretation is a group of people that travel and work together to achieve a particular purpose.
Obviously, these are metaphors. So what are the similes in these metaphors?
The important person in this allegorical entourage is the overall effect that a particular strain of cannabis has on the human body — whether or not it makes you dozy or invigorates you, chills you out or makes you edgy, dulls your pain or heightens your senses, or any combination of a plenitude of potential effects.
The metaphorical group of people supporting our VIP (overall effect) consists of the various active compounds which are present in cannabis flowers (aka marijuana buds). These two families are large and diverse and their members number in the dozens.
But who exactly are the “characters” in this entourage, what are they doing here, what are their personalities, and what are their jobs in enhancing the overall impact.
The chief active compounds that are present in cannabis resins fall into two camps. Each family of compounds is unique in its….
Read Full Article Here
The U.S. House of Representatives will be voting on a crucial amendment aimed at protecting marijuana legalization laws from federal involvement.
Almost one in four Americans live in a state the adult recreational use of marijuana is legal. Currently, these recreational markets with active dispensaries including Illinois, Massachusetts, and Nevada are not covered under protections put in place by Congress that currently protect states with medical marijuana programs. Soon, a super-important amendment to renew those protections and expand them to cover adult use could be voted on by Congress — some sources say the vote could come as early as September.
On the dark side, two other, separate amendments are being put forth by another representative that could be devastating to states with recreational programs. If passed, the measures will effectively strip federal funding from states that permit the sale of kid-friendly products or that don’t offer educational programs aimed at reducing marijuana-impaired driving.
The Marijuana Opportunity, Reinvestment and Expungement (MORE) Act was filed by lawmakers in mid-July in conjunction with a wide-ranging bill funding various federal departments in the Fiscal year 2021.
In 2014 Congress members passed yearly spending bills, including a provision protecting merchants and individuals engaged in state-sanctioned dispensing and usage of medical marijuana from prosecution by the Department of Justice. The amendment says federal funding may not be utilized to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”
This amendment would remove the word “medical” from the existing terminology and extend protections to adults and patients who qualify for a license in both recreational and medical industries. This amendment was put forth by Representatives Early Blumenauer (founding member of the Congressional Cannabis Caucus), Tom McClintock, and Eleanor Holmes-Norton.
In its current form, the spending legislation
Missouri Dispensaries are expected to start opening in August of 2020, to begin sell medical marijuana products to MO medcard holders. The MO Department of Health and Senior Services has issued 192 dispensary licenses in the state. These open cannabis stores will carry a selection of THC and CBD dispensary menu products to help qualified patients.
Missouri residents must have received your medical marijuana card from the state to be able to shop at open dispensary locations. To do this you must first visit with a certifying Marijuana Doctor in person or over your phone, tablet, or PC using Telemedicine to get certified.
With 192 dispensary locations in Missouri opening, there will be….
Visit MO Dispensaries Here
Illinois has joined ten other states in the US in legalizing marijuana for recreational use. At the time of writing, Illinois is one of only two states in the midwest along with Michigan to legalize marijuana.
Prior to Jan. 1 only medical marijuana patients were allowed to buy marijuana in Illinois. However, hemp-derived CBD oil is legal in Illinois for all residents. Other midwest states that have medical marijuana programs include Missouri and Ohio.
Here are the 5 things you need to know including a list of stores that sell marijuana in Illinois.
1) Where can I buy marijuana in Illinois? These stores:
Recreational sales will start with existing medical marijuana dispensaries on January 1st.
Here’s the complete list of Illinois recreational dispensaries:
Cannabis stores in Chicago
Sunnyside, 3812 North Clark St.
Dispensary33, 5001 North Cl…. Read More
Illinois marijuana dispensaries sold more than $47.6 million worth of products in June, according to the Illinois Department of Financial and Professional Regulation.
During that time, 994,545 items were sold, averaging almost $48 per purchase, not including taxes. Tax figures will be released later this month by the Illinois Department of Revenue.
The state most recently received $12.5 million in marijuana taxes and associated sales taxes in May, according to IDOR. That brings the state’s tax collections from marijuana legalization to $52.7 million for the five months of operation. That’s well above the $28 million estimated in this year’s budget, which ended June 30.
Towns and counties that allow marijuana sales began adding their own taxes at the beginning of this month for the first time, which will generally increase the purchase price between 3% and 3.75%.
Since legalization began…
Read Full Article Here
If you thought the stock market has been on a wild ride in 2020, pan out a bit and take a gander at the volatility that marijuana stock investors have contended with over the past couple of years. Through March 2019, you could practically have thrown a dart at a list of cannabis stocks and come out a winner. However, over the past 15 months, most pot stocks have lost half or more of their value.
As is the case with all next big thing investments, the industry needs time to mature. The good news, though, is that there is light (and plenty of green) at the end of the tunnel for cannabis stocks.
Perhaps what’ll truly vindicate marijuana as a viable investment opportunity is a publicly traded pot stock generating $1 billion in annual sales. While our neighbors to the north have their work cut out, there are three pot stocks focused on the U.S. market that do have the potential to reach $1 billion in annual sales within the next couple of years. The question is, which cannabis stock gets there first?
If the definition of “cannabis stock” includes a company whose….
Read Full Article Here
BATON ROUGE — Nearly a year after medical marijuana went from seed to shelves at nine pharmacies in Louisiana, there is a second player in a market that’s about to get a larger pool of patients suffering from a wide-open range of medical conditions.
Southern University medical marijuana licensee Ilera Holistic Healthcare shipped out its first tinctures and topical creams to pharmacies this month, joining LSU licensee Wellcana Group, which put its first tinctures on shelves last August.
Within two weeks of Wellcana hitting the retail market last year, nearly 5,000 patients entered the program, with 1,500 receiving the drug at prices between $80 and $200 to treat only about a dozen medical conditions.
Ilera is adding competition to a market in which the pharmacies have struggled with high wholesale prices and slim profit margins, while patients have complained about an unaffordable therapy that’s held back its use.
“There are a lot of Louisiana medcard patients who have tried the medicine, but the reason they weren’t continuing was the price,” H&W Dispensary owner Henry Ruston said after dropping prices.
Medical marijuana tinctures at H&W Dispensary were priced between…..
Read Full Article Here
Something called the “entourage effect.” What is this? Let’s talk about CBD, the meaning of “entourage effect”
HOW ARE CBD AND THC SIMILAR?
We started right away by talking about CBD and THC, but let’s talk about the difference between the two. And not the basic difference between the two, let’s get scientific for a moment. To explain how they’re different, let’s first talk about how they are the same. CBD and THC are both compounds that stem from the cannabis plant and they both interact with the body’s endocannabinoid system. Additionally, they even are both composed of the same molecular structure: 21 carbon atoms, 30 hydrogen atoms, and 2 oxygen atoms.
NOW, HOW ARE CBD AND THC DIFFERENT?
With all these similarities, what is the difference? The difference between THC and CBD lies in the arrangement of their atoms and how this causes different effects on the body. CBD is normally extracted from cannabis plants with low THC, called hemp. THC is extracted from cannabis plants that have been bred for high THC levels, and it is therefore called marijuana. CBD products in the U.S. that are sold legally contain less….
Read Full Article Here